{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:7581"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:7581","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The short and medium term effects of Endovascular Aneurysm Repair (EVAR) on coagulation, fibrinolysis and renal function in patients with Abdominal Aortic Aneurysms","abstract":"Background: Previous reports described activation of the haemostatic mechanism in patients with abdominal aortic aneurysm (AAA). Both open and endovascular repair of AAA affect the haemostatic markers. Cystatin C is sensitive endogenous marker of renal function that is strongly associated with cardiovascular outcomes. Aim: To establish the medium-term effects of endovascular and open aneurysm repair on coagulation, fibrinolysis and renal function. Patients and Methods: Twenty-nine patients completed twelve months follow-up after EVAR, eleven patients were recruited after they had open aneurysm repair and eight age-matched control were recruited. Patients were tested for markers of coagulation, fibrinolysis and renal function pre-operatively and at 1, 6 and 12 months post-operatively. Results: Pre-operatively, PF1+2 levels were significantly higher in patients with AAA. PF1+2 levels post-EVAR and post-OAR were significantly lower than pre-operative values and similar to AMC. There was no significant difference in TAT, PAI, or t-PA between AMC, AAA preoperatively, and post-EVAR. Post-OAR, PAI activity was significantly higher than pre-operatively. 24 hours after procedure, a significant increase in Cystatin C and serum creatinine (sCr) and significant decrease in eGFR were seen. Cystatin C increased significantly at 1, 6 and 12 months. Conclusion: AAA is associated with increased thrombin generation without up-regulation of fibrinolysis. The pro-thrombotic, hypo-fibrinolytic diathesis returns toward normal in the medium term after EVAR and OAR. EVAR is associated with a significant increase in Cystatin C 24 hours after the procedure and is maintained for 12 months. sCr and eGFR show significant change at 24 hours.","abstract_html":"Background: Previous reports described activation of the haemostatic mechanism in patients with abdominal aortic aneurysm (AAA). Both open and endovascular repair of AAA affect the haemostatic markers. Cystatin C is sensitive endogenous marker of renal function that is strongly associated with cardiovascular outcomes. Aim: To establish the medium-term effects of endovascular and open aneurysm repair on coagulation, fibrinolysis and renal function. Patients and Methods: Twenty-nine patients completed twelve months follow-up after EVAR, eleven patients were recruited after they had open aneurysm repair and eight age-matched control were recruited. Patients were tested for markers of coagulation, fibrinolysis and renal function pre-operatively and at 1, 6 and 12 months post-operatively. Results: Pre-operatively, PF1+2 levels were significantly higher in patients with AAA. PF1+2 levels post-EVAR and post-OAR were significantly lower than pre-operative values and similar to AMC. There was no significant difference in TAT, PAI, or t-PA between AMC, AAA preoperatively, and post-EVAR. Post-OAR, PAI activity was significantly higher than pre-operatively. 24 hours after procedure, a significant increase in Cystatin C and serum creatinine (sCr) and significant decrease in eGFR were seen. Cystatin C increased significantly at 1, 6 and 12 months. Conclusion: AAA is associated with increased thrombin generation without up-regulation of fibrinolysis. The pro-thrombotic, hypo-fibrinolytic diathesis returns toward normal in the medium term after EVAR and OAR. EVAR is associated with a significant increase in Cystatin C 24 hours after the procedure and is maintained for 12 months. sCr and eGFR show significant change at 24 hours.","abstract_has_math":false,"creators":["Abdelhamid, Mohamed Farouk Aly"],"institution":"University of Birmingham","degree_name":"h_md","degree_level":"h_md","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-07","date_published":"2017-07","updated_at":"2026-11-19T09:29:31Z","subjects":["R Medicine (General)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/7581/1/Abdelhamid17MD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A7581","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Abdelhamid, Mohamed Farouk Aly"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-07"]},{"key":"dc:date.issued","label":"Date","values":["2017-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Medical School"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/7581/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["h_md"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["h_md"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/7581/1/Abdelhamid17MD.pdf","http://etheses.bham.ac.uk//id/eprint/7581/2/Decl_IS_Abdelhamid17MD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Background: Previous reports described activation of the haemostatic mechanism in patients with abdominal aortic aneurysm (AAA). Both open and endovascular repair of AAA affect the haemostatic markers. Cystatin C is sensitive endogenous marker of renal function that is strongly associated with cardiovascular outcomes. Aim: To establish the medium-term effects of endovascular and open aneurysm repair on coagulation, fibrinolysis and renal function. Patients and Methods: Twenty-nine patients completed twelve months follow-up after EVAR, eleven patients were recruited after they had open aneurysm repair and eight age-matched control were recruited. Patients were tested for markers of coagulation, fibrinolysis and renal function pre-operatively and at 1, 6 and 12 months post-operatively. Results: Pre-operatively, PF1+2 levels were significantly higher in patients with AAA. PF1+2 levels post-EVAR and post-OAR were significantly lower than pre-operative values and similar to AMC. There was no significant difference in TAT, PAI, or t-PA between AMC, AAA preoperatively, and post-EVAR. Post-OAR, PAI activity was significantly higher than pre-operatively. 24 hours after procedure, a significant increase in Cystatin C and serum creatinine (sCr) and significant decrease in eGFR were seen. Cystatin C increased significantly at 1, 6 and 12 months. Conclusion: AAA is associated with increased thrombin generation without up-regulation of fibrinolysis. The pro-thrombotic, hypo-fibrinolytic diathesis returns toward normal in the medium term after EVAR and OAR. EVAR is associated with a significant increase in Cystatin C 24 hours after the procedure and is maintained for 12 months. sCr and eGFR show significant change at 24 hours."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["The short and medium term effects of Endovascular Aneurysm Repair (EVAR) on coagulation, fibrinolysis and renal function in patients with Abdominal Aortic Aneurysms"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Abdelhamid, Mohamed Farouk Aly"],"dc:date":["2017-07"],"dc:date.issued":["2017-07"],"dc:description.abstract":["Background: Previous reports described activation of the haemostatic mechanism in patients with abdominal aortic aneurysm (AAA). Both open and endovascular repair of AAA affect the haemostatic markers. Cystatin C is sensitive endogenous marker of renal function that is strongly associated with cardiovascular outcomes. Aim: To establish the medium-term effects of endovascular and open aneurysm repair on coagulation, fibrinolysis and renal function. Patients and Methods: Twenty-nine patients completed twelve months follow-up after EVAR, eleven patients were recruited after they had open aneurysm repair and eight age-matched control were recruited. Patients were tested for markers of coagulation, fibrinolysis and renal function pre-operatively and at 1, 6 and 12 months post-operatively. Results: Pre-operatively, PF1+2 levels were significantly higher in patients with AAA. PF1+2 levels post-EVAR and post-OAR were significantly lower than pre-operative values and similar to AMC. There was no significant difference in TAT, PAI, or t-PA between AMC, AAA preoperatively, and post-EVAR. Post-OAR, PAI activity was significantly higher than pre-operatively. 24 hours after procedure, a significant increase in Cystatin C and serum creatinine (sCr) and significant decrease in eGFR were seen. Cystatin C increased significantly at 1, 6 and 12 months. Conclusion: AAA is associated with increased thrombin generation without up-regulation of fibrinolysis. The pro-thrombotic, hypo-fibrinolytic diathesis returns toward normal in the medium term after EVAR and OAR. EVAR is associated with a significant increase in Cystatin C 24 hours after the procedure and is maintained for 12 months. sCr and eGFR show significant change at 24 hours."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/7581/1/Abdelhamid17MD.pdf","http://etheses.bham.ac.uk//id/eprint/7581/2/Decl_IS_Abdelhamid17MD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Medical School"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/7581/"],"dc:subject":["R Medicine (General)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["The short and medium term effects of Endovascular Aneurysm Repair (EVAR) on coagulation, fibrinolysis and renal function in patients with Abdominal Aortic Aneurysms"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["h_md"],"dc:type.qualificationname":["h_md"]},"updated_at":"2026-11-19T09:29:31Z"}